ARCA Biopharma Inc (ABIO): $ABIO ARCA biopharma, Inc. operates as a...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

ARCA Biopharma Inc (ABIO)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	898
Posts	148975
Boards Moderated	0
Alias Born	08/13/2010

Re: Popcorncharts post# 2367

Thursday, 10/15/2020 12:27:05 PM

Thursday, October 15, 2020 12:27:05 PM

$ABIO ARCA biopharma, Inc. operates as a biopharmaceutical company applying a precision medicine approach to developing and commercializing genetically targeted therapies for cardiovascular diseases. Its lead product candidate, Gencaro (bucindolol hydrochloride) is pharmacogenetically-targeted beta-adrenergic receptor antagonist, which is in the development for the treatment of atrial fibrillation in certain patients who also have heart failure (HF). The company also engages in the development of AB171, a thiol-substituted isosorbide mononitrate for the treatment of HF and peripheral arterial disease. ARCA biopharma, Inc. is headquartered in Westminster, Colorado.

Nothing I say, post, or do should ever be considered financial advice. I may be holding a long, short or no position. I am NOT or NEVER have I been compensated to post on here or anywhere and all my posts are for entertainment purposes only.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent ABIO News

ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 04/25/2024 08:15:00 PM
Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law Firm • PR Newswire (US) • 04/05/2024 05:09:00 PM
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement • GlobeNewswire Inc. • 04/03/2024 11:30:00 AM
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement • GlobeNewswire Inc. • 04/03/2024 11:30:00 AM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/07/2024 06:08:47 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 09:15:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 09:39:21 PM
ARCA biopharma Announces 2023 Financial Results • GlobeNewswire Inc. • 02/01/2024 09:35:07 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/01/2024 09:15:34 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 11:39:46 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 09:25:37 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 09:25:36 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 09:25:28 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 09:25:24 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 09:25:19 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 09:25:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 09:15:13 PM
Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 12/19/2023 09:25:05 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 12/19/2023 09:20:02 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/19/2023 09:15:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 09:36:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/18/2023 08:35:08 PM
ARCA biopharma Announces Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 10/18/2023 08:25:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/18/2023 08:15:25 PM

More ABIO News

InvestorsHub NewsWire

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow